PolyPeptide Group AG (PPGN) — Financial Flexibility Index
PolyPeptide Group AG (PPGN) has a Financial Flexibility Index of 0.22x as of June 2025. Free cash flow of CHF98.34 Million (operating CF CHF49.66 Million minus capex CHF48.68 Million) represents 0% of total liabilities (CHF442.08 Million). Check PPGN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PolyPeptide Group AG Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for PolyPeptide Group AG across 7 annual periods. For the full cash flow conversion analysis, see PPGN cash flow conversion.
Annual Financial Flexibility Index for PolyPeptide Group AG (2018–2024)
Year-by-year free cash flow to debt coverage for PolyPeptide Group AG. Explore how well can PolyPeptide Group AG service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.44x | CHF176.37 Million | CHF89.40 Million | CHF399.33 Million | ▲ +45.9% |
| 2023 | 0.30x | CHF93.22 Million | CHF36.48 Million | CHF307.86 Million | ▼ -44.6% |
| 2022 | 0.55x | CHF84.22 Million | CHF5.46 Million | CHF154.10 Million | ▼ -29.6% |
| 2021 | 0.78x | CHF135.06 Million | CHF57.35 Million | CHF173.87 Million | ▲ +71.0% |
| 2020 | 0.45x | CHF90.10 Million | CHF49.48 Million | CHF198.31 Million | ▼ -6.0% |
| 2019 | 0.48x | CHF75.31 Million | CHF55.60 Million | CHF155.73 Million | ▲ +59.6% |
| 2018 | 0.30x | CHF41.24 Million | CHF22.94 Million | CHF136.15 Million | — |